Targeted chemotherapy, the medical ecosystem, and the future of American health care.

@article{Gillick2014TargetedCT,
  title={Targeted chemotherapy, the medical ecosystem, and the future of American health care.},
  author={Muriel R. Gillick},
  journal={Perspectives in biology and medicine},
  year={2014},
  volume={57 2},
  pages={
          268-84
        }
}
In light of the difficulties experienced by the pharmaceutical industry in developing important new drugs, the rapid design and introduction of the targeted chemotherapeutic agent, crizotinib, is a significant achievement. Understanding the roles of the patient, the physician, the regulator (FDA), health insurance companies, and the manufacturer (Pfizer) in the development of this drug can shed light on the prospects for future drugs and on the workings of the complicated health-care ecosystem… CONTINUE READING